Diclofenac Potassium + ParacetamolThird Party Manufacturing in India

Diclofenac Potassium + Paracetamol is a well-established fixed-dose combination that delivers dual-mode analgesia through complementary mechanisms of action.

Diclofenac potassium, a phenylacetic acid derivative NSAID, works by inhibiting cyclooxygenase-1 and cyclooxygenase-2 enzymes. These enzymes catalyze the conversion of arachidonic acid to prostaglandin G2, the precursor of prostaglandins, prostacyclin, and thromboxanes. By blocking prostaglandin synthesis, diclofenac reduces inflammation, pain, and fever at the peripheral tissue level. Diclofenac shows preferential inhibition of COX-2 over COX-1, which contributes to its potent anti-inflammatory activity. It also influences the lipoxygenase pathway, reducing leukotriene formation, and has been shown to activate the nitric oxide-cGMP antinociceptive pathway.

Paracetamol, though its exact mechanism is not fully understood, is believed to act primarily in the central nervous system. It is thought to inhibit a brain-specific isoform of cyclooxygenase, reducing prostaglandin synthesis in the hypothalamus. Paracetamol also modulates the serotonergic descending pain pathways and activates cannabinoid CB1 receptors through its metabolite AM404. It provides effective antipyretic and analgesic activity with minimal peripheral anti-inflammatory effect.

The combination provides rapid-onset analgesia with diclofenac potassium acting peripherally on inflammation while paracetamol works centrally on pain perception, resulting in enhanced pain relief with a favorable safety profile.

Therapeutic Uses

Diclofenac Potassium + Paracetamol is prescribed for the treatment of:

• Acute Pain Conditions: Effective for short-term management of acute musculoskeletal pain, dental pain, postoperative pain, dysmenorrhea, and headache. The combination provides faster onset of action compared to either agent alone due to the rapid absorption of diclofenac potassium.
• Inflammatory Pain: Diclofenac potassium addresses the inflammatory component of pain conditions including rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and acute gout attacks by inhibiting prostaglandin synthesis at the site of inflammation.
• Fever and Pyrexia: Paracetamol provides effective antipyretic action by acting on the hypothalamic heat-regulating center, making this combination suitable for febrile conditions accompanied by body pain.
• Dental Pain: Following dental extractions or procedures, this combination offers reliable pain relief by targeting both the inflammatory response at the surgical site and the central pain pathways.
• Dysmenorrhea: The combination effectively manages menstrual cramps by reducing uterine prostaglandin production and providing central pain relief.

Why Manufacturers Choose Diclofenac Potassium + Paracetamol

This is one of the most widely prescribed analgesic combinations in India and across global markets. Its popularity stems from the synergistic action of two well-established molecules with proven safety profiles. The combination is available in multiple strengths, allowing manufacturers to serve both prescription and OTC market segments. Diclofenac potassium offers faster absorption than diclofenac sodium, providing rapid pain relief that patients prefer. Indian WHO-GMP certified manufacturers produce this combination in high volumes for both domestic PCD franchise distribution and export to markets across Asia, Africa, and Latin America. The manufacturing infrastructure for tablet production is well-established, making this a reliable high-volume product for contract manufacturing operations.